MET and lung cancer: The authors also tested other cell lines, including other lung cancer, melanoma, colorectal cancer, and breast cancer cell lines, and observed the selection of a similar subpopulation of drug-tolerant persister cells after exposure to various drugs (cisplatin, EGFR inhibitors, RAF inhibitor, and MET inhibitor).